Chase S. Hall, M.D.
Dr. Chase S. Hall is an Assistant Professor of Medicine at the University of Kansas Medical Center in the Division of Pulmonary and Critical Care. He specializes in interstitial and rare lung diseases.
Dr. Hall received his medical degree from the University of Kansas School of Medicine. He completed his residency training in Internal Medicine and at Washington University School of Medicine in St. Louis. He remained at Washington University for his fellowship in Pulmonary and Critical Care and completed a post-doctoral research fellowship in Dr. Castro's Lab.
Education and Training
- BS, Life Sciences, Kansas State University, Manhattan, Kansas
- MD, Medicine, University of Kansas Medical Center, Kansas City, Kansas
- Residency, Internal Medicine, Washington University / Barnes Jewish Hospital, St. Louis, Missouri
- Clinical Fellowship, Pulmonary and Critical Care, Washington University / Barnes Jewish Hospital, St. Louis, Missouri
- Post Doctoral Fellowship, Pulmonary and Critical Care, Washington University / Barnes Jewish Hospital, St. Louis, Missouri
Licensure, Accreditations & Certifications
- Diplomate, American Board of Internal Medicine, ABIM
- Diplomate, American Board of Internal Medicine, Critical Care Medicine , ABIM
- Diplomate, American Board of Internal Medicine, Pulmonary Diseases, ABIM
- Kansas Medical License, Kansas Board of Healing Arts
- Missouri Medical License, Missouri Board of Healing Arts
- 129Xe MRI Clinical Trials Consortium, Member, 2021 - Present
- Polarean Scientific Advisory Board, Member, 2021 - Present
- The LAM Foundation, Early Stage Investigator, Co-Chair, 2020 - 2020
- American College of Chest Physicians, Member, 2018 - Present
My fellowship research experience included 2.5 years of post-doctoral research training in the Asthma and Airway Translational Research Unit (AATRU) under the mentorship of Dr. Mario Castro. My research focus has been in establishing imaging biomarkers in respiratory disease, with a historical focus in airway and interstitial lung diseases. We utilize both volumetric computed chest tomography (CT) and 129Xe lung MRI.
Recently, we completed a double-blind, parallel assignment pilot study evaluating the efficacy and safety of image-guided bronchial thermoplasty. In this study, a single session of 129Xe MR image-guided BT was compared to standard three session BT.
Currently, we are utilizing the unique properties of 129Xe MRI to develop sensitive imaging biomarkers of treatment response in a number of respiratory diseases. We have focused on protocol development to speed up image acquisition time as well as develop fully automated image analysis programs. Our image analysis pipelines of both CT and 129Xe MRI integrate image segmentation using convolutional neural networks to improve accuracy and reduce time.
We are a member of the 129Xe MRI Clinical Trials Consortium.
Current Research and Grants
- 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study, Boehringer Ingelheim, PI, PI